![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-10-2024-51523.pdf
https://www.fiercepharma.com/manufacturing/accord-healthcare-restarts-production-cancer-drug-cisplatin
https://www.ema.europa.eu/en/documents/overview/degarelix-accord-epar-medicine-overview_en.pdf
https://www.reuters.com/business/healthcare-pharmaceuticals/accord-resumes-production-cancer-drug-methotrexate-amid-supply-shortage-2023-11-07/
https://www.prnewswire.com/news-releases/accord-and-hipra-enter-into-exclusive-distribution-agreement-to-commercialise-hipras-covid-19-vaccine-bimervax-in-the-united-kingdom-301892785.html
https://www.ema.europa.eu/en/documents/overview/voriconazole-accord-epar-summary-public_en.pdf
https://www.ema.europa.eu/en/documents/overview/dabigatran-etexilate-accord-epar-medicine-overview_en.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2023-46659.pdf
https://www.prnewswire.com/news-releases/accord-healthcare-adds-generic-drug-approved-for-the-treatment-of-relapsing-ms-301770076.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf